Barrière J - Search Results

1

[The fight against scientific fraud: A thankless but necessary task].

Barrière J, Frank F, Besancon L, Samuel A, Saada V, Billy E, Seitz-Polski B, Robert J. Barrière J, et al. Bull Cancer. 2022 Oct;109(10):996-998. doi: 10.1016/j.bulcan.2022.06.013. Epub 2022 Aug 31. Bull Cancer. 2022. PMID: 36055805 French. No abstract available.

2

[We must respect the anti-SARS-CoV-2 vaccine schedule without delay in cancer patients under treatment].

Barrière J, Audigier-Valette C, Borchiellini D, Hoch B, Castelnau O, Francois E, Gastaud L, Skaf R, Berdah JF, Marie W, Lescaut W, Peyrade F, Cluzeau T, Cassuto O, Carles M. Barrière J, et al. Bull Cancer. 2021 Apr;108(4):341-342. doi: 10.1016/j.bulcan.2021.02.003. Epub 2021 Mar 5. Bull Cancer. 2021. PMID: 33741139 Free PMC article. French. No abstract available.

3

Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article.

Barrière J, Carles M, Audigier-Valette C, Re D, Adjtoutah Z, Seitz-Polski B, Gounant V, Descamps D, Zalcman G. Barrière J, et al. Eur J Cancer. 2022 Feb;162:182-193. doi: 10.1016/j.ejca.2021.12.011. Epub 2021 Dec 16. Eur J Cancer. 2022. PMID: 35016032 Free PMC article. Review.

4

[Recommendations to protect patients with cancer against the Omicron variant].

Barrière J, Zalcman G, Fignon L, Peiffer-Smadja N, Audigier-Valette C, Carles M. Barrière J, et al. Bull Cancer. 2022 Feb;109(2):115-118. doi: 10.1016/j.bulcan.2021.12.007. Epub 2022 Jan 11. Bull Cancer. 2022. PMID: 35031126 Free PMC article. French. No abstract available.

5

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies.

Re D, Seitz-Polski B, Brglez V, Carles M, Graça D, Benzaken S, Liguori S, Zahreddine K, Delforge M, Bailly-Maitre B, Verrière B, Chamorey E, Barrière J. Re D, et al. Among authors: barriere j. Nat Commun. 2022 Feb 14;13(1):864. doi: 10.1038/s41467-022-28578-0. Nat Commun. 2022. PMID: 35165284 Free PMC article.

6

Low baseline IFN-γ response could predict hospitalization in COVID-19 patients.

Cremoni M, Allouche J, Graça D, Zorzi K, Fernandez C, Teisseyre M, Benzaken S, Ruetsch-Chelli C, Esnault VLM, Dellamonica J, Carles M, Barrière J, Ticchioni M, Brglez V, Seitz-Polski B. Cremoni M, et al. Among authors: barriere j. Front Immunol. 2022 Sep 26;13:953502. doi: 10.3389/fimmu.2022.953502. eCollection 2022. Front Immunol. 2022. PMID: 36225915 Free PMC article.

7

Scientific Integrity Requires Publishing Rebuttals and Retracting Problematic Papers.

Barrière J, Frank F, Besançon L, Samuel A, Saada V, Billy E, Al-Ahmad A, Seitz-Polski B, Robert J. Barrière J, et al. Stem Cell Rev Rep. 2023 Feb;19(2):568-572. doi: 10.1007/s12015-022-10465-2. Epub 2022 Oct 26. Stem Cell Rev Rep. 2023. PMID: 36287337 Free PMC article.

8

Humoral and cellular responses after a third dose of SARS-CoV-2 mRNA vaccine in patients with glomerular disease.

Teisseyre M, Graça D, Re D, Cremoni M, Benzaken S, Zorzi K, Fernandez C, Esnault VLM, Barrière J, Brglez V, Seitz-Polski B. Teisseyre M, et al. Among authors: barriere j. Nephrol Dial Transplant. 2023 Jan 23;38(1):249-251. doi: 10.1093/ndt/gfac294. Nephrol Dial Transplant. 2023. PMID: 36352472 No abstract available.

9

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses.

Buscot M, Cremoni M, Graça D, Brglez V, Courjon J, Allouche J, Teisseyre M, Boyer L, Barrière J, Chamorey E, Carles M, Seitz-Polski B. Buscot M, et al. Among authors: barriere j. Front Immunol. 2023 Mar 30;14:1145652. doi: 10.3389/fimmu.2023.1145652. eCollection 2023. Front Immunol. 2023. PMID: 37063916 Free PMC article.

10

Raising concerns on questionable ethics approvals - a case study of 456 trials from the Institut Hospitalo-Universitaire Méditerranée Infection.

Frank F, Florens N, Meyerowitz-Katz G, Barriere J, Billy É, Saada V, Samuel A, Robert J, Besançon L. Frank F, et al. Among authors: barriere j. Res Integr Peer Rev. 2023 Aug 3;8(1):9. doi: 10.1186/s41073-023-00134-4. Res Integr Peer Rev. 2023. PMID: 37533089 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page